Rocket Lab is executing a high-risk, high-reward transition from small-lift (Electron) to medium-lift (Neutron) and high-margin space systems. The current valuation prices in flawless execution and capturing significant orbital market share from SpaceX. Fair value range: low $14.9, high $28.8, with mid-point at $21.2.
Engelse bron wordt weergegeven terwijl we vertalen
Dit rapport is nog niet vertaald. Vernieuw over een paar minuten zodra de vertaalwachtrij is bijgewerkt.
§1 Samenvatting
Extreme market disconnect: 62% implied growth gap required to justify current price.
Heavy reliance on a single relative valuation model (EV/Revenue) due to massive cash burn.
Significant capital intensity and dilution execution risk during the Neutron buildout phase.
Fair value
$21
Margin of safety
-533.1%
Confidence
53/100
Moat
3/10
Educational research only - not investment advice, an offer, or a trade instruction. Confirm current data and do your own due diligence before acting.
$134.28Price
Low $14.89
Mid $21.21
High $28.80
Rocket Lab is executing a high-risk, high-reward transition from small-lift (Electron) to medium-lift (Neutron) and high-margin space systems. The current valuation prices in flawless execution and capturing significant orbital market share from SpaceX.
Cycle upside
Surging demand for mega-constellations and sovereign space infrastructure driving inelastic launch and hardware demand.
Free cash flow for RKLB (RKLB) is computed as operating cash flow minus capital expenditure. We report both the absolute level and the FCF margin against revenue, with five years of trajectory.
Operating cash flow is the primary signal: when OCF is negative or significantly below net income, the cash-flow subsection flags the divergence and traces the cause to working-capital, deferred-revenue, or earnings-quality effects.
Capital expenditure is reported as a percentage of revenue alongside the absolute number. Heavy investment phases are separated from harvesting phases so reinvestment intent is legible.
The financing activity row tracks dividends paid, share repurchases, and net debt issuance. Together with FCF, it answers whether buybacks and dividends are funded organically or by issuing debt.
FAQ
RKLB — frequently asked questions
Based on our latest analysis, RKLB looks meaningfully overvalued. The current price is $134 versus a composite fair-value midpoint of $21.2 (range $14.9–$28.8), which implies roughly 84.2% downside to the midpoint.
Our composite fair-value range for RKLB is $14.9–$28.8, with a midpoint of $21.2. The range is triangulated across multiple valuation models (discounted earnings, forward earnings scenarios, peer multiples, and where applicable owner earnings or reverse DCF) and weighted by reliability for RKLB's archetype.
Our current rating for RKLB is Sell with a confidence score of 53/100. Sell. Rocket Lab is executing a high-risk, high-reward transition, but current valuation prices in flawless execution and captures a 62-point implied growth gap against realistic targets. This is research for educational purposes, not personalized investment advice.
The top risks our latest report flags for RKLB are: Neutron Development Failure; SpaceX Rideshare Pricing War; Catastrophic Dilutive Capital Raise. The single biggest risk is Neutron Development Failure: Neutron experiences costly delays or launch failures, forcing highly dilutive capital raises while legacy primes compress margins.
Our current rating for RKLB is Sell, issued with a confidence score of 53/100 and a moat score of 3/10. The rating reflects the composite fair-value range ($14.9–$28.8) versus the current price of $134.
RKLB is classified as a pre-profit stock. Archetype determines how every downstream parameter — discount rate, terminal growth, deceleration curve, terminal multiple, scenario probability weights, scorecard weights, and which valuation models are prioritized — is calibrated for RKLB.